EVARF — Lombard Medical Cashflow Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual cashflow statement for Lombard Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2012 December 31st | C2013 December 31st | C2014 December 31st | 2015 December 31st | 2016 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 20-F | 20-F | 20-F | 20-F |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -13.7 | -20.3 | -36 | -40 | -32.5 |
Depreciation | |||||
Non-Cash Items | 0.222 | 1.46 | 2.38 | 3.57 | 8.49 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 1.27 | 0.53 | -1.94 | 0.854 | -3.31 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -11.9 | -17.8 | -34.4 | -33.8 | -25.2 |
Capital Expenditures | -0.218 | -3.88 | -1.75 | -1.25 | -0.265 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | — | 0.124 | 0.167 | -0.113 | 0.171 |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.218 | -3.75 | -1.58 | -1.37 | -0.094 |
Financing Cash Flow Items | 0 | -2.34 | -5.34 | -1.13 | -1.6 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 4.53 | 55.5 | 49.7 | 14.5 | 15.8 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -7.17 | 36.4 | 12.5 | -21 | -11.5 |